Preparation and Evaluation of Lipid-Based Liquid Crystalline Formulation of Fenofibrate.

Conclusions: In the most formulations of FFB LCs, the DE% was more than the pure drug, and therefore, it seems that the liquid crystalline formulations can be effective for enhancing drug release. Furthermore, drug release rate depended on the stabilizer type so that the presence of colloidal silica caused slower drug release compared to Pluronic F127. PMID: 30310774 [PubMed]
Source: Biomed Res - Category: Research Authors: Tags: Adv Biomed Res Source Type: research
More News: Fenofibrate | Research | Study | Tricor